Skip to content
healthcare.dev

Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension

NDC 68788-7787, neomycin and polymyxin B sulfates and hydrocortisone otic, suspension, from Preferred Pharmaceuticals, Inc..

Product NDC
68788-7787
Status
Listed
Labeler
Preferred Pharmaceuticals, Inc.
Dosage form
SUSPENSION
Route
AURICULAR (OTIC)
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA060613
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68788-7787 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDROCORTISONE10 mg/mL
  • NEOMYCIN SULFATE3.5 mg/mL
  • POLYMYXIN B SULFATE10000 [USP'U]/mL

Pharmacologic classes

Aminoglycoside Antibacterial [EPC]; Aminoglycosides [CS]; Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; Polymyxin-class Antibacterial [EPC]; Polymyxins [CS]

Package NDCNDC-11Package
68788-7787-1687887787011 BOTTLE in 1 CARTON (68788-7787-1) / 10 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5f17fae0-c6ea-452e-b84f-066caf2a95fc

Use it

Look up 68788-7787 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68788-7787 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68788-7787. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.